Nordic Life Science
Advertising
Nordic Life Science
The latest business news
The company will receive a 500 000 SEK grant from Sweden’s government agency for innovation, Vinnova, for the project “Verification of the unique functionality of ATOR-1017 by 3D structure determination”.
AstraZeneca and Merck & Co have announced that they were granted orphan drug designation (ODD) by the US Food and Drug Administration (FDA) for Lynparza (olaparib) for the treatment of pancreatic cancer.
Fredrik Almqvist, Professor in organic chemistry at Umeå University, and his American research colleague Christina Stallings, receive SEK 24 million from the National Institutes of Health (NIH) for research for
The company announces plans to reduce activities not critical to its development pipeline of drug candidates as part of its enhanced focus on clinical stage projects, it lays off 60
Immunicum raises SEK 351M in a directed issue and a fully guaranteed rights issue for continued clinical development of Ilixadencel – a new cancer immunotherapy. On 16 October 2018, the
The company is strengthening its presence in the US market through a recruitment of Dr. Joshua J. Schmidt as Business Development Director at SenzaGen Inc. The appointment represents a further
Advertising
Drug & Device development
Swedish Orphan Biovitrum AB (Sobi) releases the primary efficacy results from the phase 2 study with anakinra in patients with acute gout – the anaGO study. For the primary endpoint
The company is strengthening its presence in the US market through a recruitment of Dr. Joshua J. Schmidt as Business Development Director at SenzaGen Inc. The appointment represents a further
In an in-vivo study involving 16 New Zeeland White rabbits Xlucane (ranibizumab (Lucentis) biosimilar) demonstrated equivalent tolerability and pharmacokinetic profile in the serum and in the vitreous body compared to
The company announced last week that a major Nordic study will begin using their PET imaging agent ABY-025. ABY-025 is a novel Affibody molecule imaging tracer that can identify HER2
Somapacitan, a novel growth hormone derivative in development for once-weekly administration of growth hormone, matched the therapeutic benefits of once-daily Norditropin (somatropin) in a phase 2 trial in children with
AstraZeneca and MedImmune have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi during the Presidential Symposium of the IASLC 19th World Conference on Lung
MLM’s junior staff honored by the chamber of commerce and industry 10 October 2018 by MLM Medical Labs
Nanoplastics in your drinking water – specifying the what's and how much 3 October 2018 by Smile Incubator
The company will receive a 500 000 SEK grant from Sweden’s government agency for innovation, Vinnova, for the project “Verification of the unique functionality of ATOR-1017 by 3D structure determination”.
Advertising
Latest news
Swedish Orphan Biovitrum AB (Sobi) releases the primary efficacy results from the phase 2 study with anakinra in patients with acute gout – the anaGO study. For the primary endpoint
MLM’s junior staff honored by the chamber of commerce and industry 10 October 2018 by MLM Medical Labs
Nanoplastics in your drinking water – specifying the what's and how much 3 October 2018 by Smile Incubator
Our region is filled with life science activity. We take a closer look at what´s going in our Nordic cities when it comes to life science efforts, progress and challenges.
In focus – Nordic cities
Nordic Life Science
The latest clinical trials
Swedish Orphan Biovitrum AB (Sobi) releases the primary efficacy results from the phase 2 study with anakinra in patients with acute gout – the anaGO study. For the primary endpoint
In an in-vivo study involving 16 New Zeeland White rabbits Xlucane (ranibizumab (Lucentis) biosimilar) demonstrated equivalent tolerability and pharmacokinetic profile in the serum and in the vitreous body compared to
The company announced last week that a major Nordic study will begin using their PET imaging agent ABY-025. ABY-025 is a novel Affibody molecule imaging tracer that can identify HER2
Somapacitan, a novel growth hormone derivative in development for once-weekly administration of growth hormone, matched the therapeutic benefits of once-daily Norditropin (somatropin) in a phase 2 trial in children with
AstraZeneca and MedImmune have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi during the Presidential Symposium of the IASLC 19th World Conference on Lung
The first patient has been dosed in a Phase 2 study evaluating the combination therapy of the company’s cancer immunotherapy, CV301, and Roches’s checkpoint inhibitor, atezolizumab (TECENTRIQ), for the treatment
The company announces results from their BORA Phase III extension trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as an add-on maintenance treatment in patients with severe eosinophilic asthma who
Moberg Pharma has completed the recruitment of 365 patients with onychomycosis (nail fungus) for the ongoing MOB-015 phase 3 study in North America. The aim is to provide a pivotal
Ozempic consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal stroke or cardiovascular death (i.e. adverse cardiovascular events, MACE) in people
The latest research news from the Nordic region
Science Article
Fredrik Almqvist, Professor in organic chemistry at Umeå University, and his American research colleague Christina Stallings, receive SEK 24 million from the National Institutes of Health (NIH) for research for
Researchers of organic chemistry and biotechnology from the University of Turku are creating new medical technologies in an Ecosystem coordinated by Orion Corporation. Together with selected university research groups and
Researchers at Karolinska Institutet have examined how effective immunological checkpoint therapy is for individuals with inherited CDKN2A mutation and metastatic melanoma. In recent years, new immunological treatments have appeared that
This week, the Nobel Prizes in Physiology or Medicine, Physics and Chemistry were announced, and all three of them have important life science applications, including cancer immunotherapy, eye operations and the production
This year’s Eric K. Fernström foundation Grand Nordic Prize goes to neurology researcher Maiken Nedergaard, at the University of Copenhagen and the University of Rochester. Nedergaard has discovered and investigated
Researchers at Karolinska Institutet have identified four types of neurons in the peripheral auditory system, three of which are new to science, they report Previously, most of the ear’s nerve